TEZAMPANEL

Phase 2Small molecule

TTorreyPines Therapeutics

TEZAMPANEL is one of 66 small molecule programs targeting Migraine. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

MigraineActive, not recruiting

Opioid Use DisorderActive, not recruiting

MigrainePhase 2

Active, not recruiting

Opioid Use DisorderPhase 1

Active, not recruiting

Competition

Competitive Landscape

357 competitors in Migraine

#DrugCompanyPhaseTrials

Aimovig

Amgen

Preclinical

33 2

Emgality

Eli Lilly

Preclinical

19 3

Vyepti

Lundbeck

Preclinical

12 4

Savella

AbbVie

Preclinical

2 5

Adempas

Bayer

Preclinical

1 6

Cervidil

Pfizer

Preclinical

1 7

Botox

RRevance Therapeutics, Inc.

Preclinical

9 8

Viagra

VViatris Specialty LLC

Preclinical

2 9

Nitrostat

VViatris Specialty LLC

Preclinical

2 10

TEZAMPANEL

TTorreyPines Therapeutics

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Migraine1 trial

Study to Assess the Safety, Tolerance and Efficacy of Tezampanel in Patients With Acute Migraine

Completed·TTorreyPines Therapeutics·Phase 2·NCT00567086·306 enrolled

Opioid Use Disorder1 trial

Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder

Recruiting·PProniras Corporation·Phase 1·NCT06538558·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for TEZAMPANEL. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — TEZAMPANEL compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for TEZAMPANEL. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — TorreyPines Therapeutics company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: TTorreyPines Therapeutics

TEZAMPANEL

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Migraine1 trial

Opioid Use Disorder1 trial

References

Drug Info

Quick Facts

Related News